nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxprenolol—ADRB2—polycystic ovary syndrome	0.635	1	CbGaD
Oxprenolol—SLC22A2—Metformin—polycystic ovary syndrome	0.251	1	CbGbCtD
Oxprenolol—Alprenolol—ADRB3—polycystic ovary syndrome	0.00114	0.14	CrCbGaD
Oxprenolol—Pindolol—ADRB3—polycystic ovary syndrome	0.000981	0.121	CrCbGaD
Oxprenolol—Metipranolol—ADRB2—polycystic ovary syndrome	0.000746	0.0919	CrCbGaD
Oxprenolol—Esmolol—ADRB2—polycystic ovary syndrome	0.000593	0.073	CrCbGaD
Oxprenolol—Propranolol—ADRB3—polycystic ovary syndrome	0.000535	0.0659	CrCbGaD
Oxprenolol—Betaxolol—ADRB2—polycystic ovary syndrome	0.000522	0.0643	CrCbGaD
Oxprenolol—Penbutolol—ADRB2—polycystic ovary syndrome	0.000517	0.0637	CrCbGaD
Oxprenolol—Atenolol—ADRB2—polycystic ovary syndrome	0.000517	0.0637	CrCbGaD
Oxprenolol—Emotional distress—Metformin—polycystic ovary syndrome	0.000514	0.284	CcSEcCtD
Oxprenolol—Bisoprolol—ADRB2—polycystic ovary syndrome	0.000504	0.0621	CrCbGaD
Oxprenolol—Acebutolol—ADRB2—polycystic ovary syndrome	0.000477	0.0588	CrCbGaD
Oxprenolol—Alprenolol—ADRB2—polycystic ovary syndrome	0.000433	0.0534	CrCbGaD
Oxprenolol—Metoprolol—ADRB2—polycystic ovary syndrome	0.000403	0.0496	CrCbGaD
Oxprenolol—Pindolol—ADRB2—polycystic ovary syndrome	0.000373	0.0459	CrCbGaD
Oxprenolol—Propranolol—ADRB2—polycystic ovary syndrome	0.000203	0.0251	CrCbGaD
Oxprenolol—Propranolol—CYP1A1—polycystic ovary syndrome	0.000174	0.0215	CrCbGaD
Oxprenolol—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.000163	0.0898	CcSEcCtD
Oxprenolol—Sweating increased—Metformin—polycystic ovary syndrome	0.000134	0.0738	CcSEcCtD
Oxprenolol—Bradycardia—Metformin—polycystic ovary syndrome	0.000112	0.0617	CcSEcCtD
Oxprenolol—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000111	0.00106	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.000109	0.00105	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000109	0.00105	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.000108	0.00104	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.000108	0.00104	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.000108	0.00104	CbGpPWpGaD
Oxprenolol—CYP2D6—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000108	0.00104	CbGpPWpGaD
Oxprenolol—CYP2D6—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000106	0.00102	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.000106	0.00102	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.000106	0.00102	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.000106	0.00102	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000105	0.00101	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000103	0.000992	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.000101	0.000975	CbGpPWpGaD
Oxprenolol—CYP2D6—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.0001	0.000965	CbGpPWpGaD
Oxprenolol—CYP2D6—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.0001	0.000964	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—LPCAT2—polycystic ovary syndrome	9.99e-05	0.000961	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—SUOX—polycystic ovary syndrome	9.99e-05	0.000961	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PTAFR—polycystic ovary syndrome	9.92e-05	0.000954	CbGpPWpGaD
Oxprenolol—CYP2D6—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	9.88e-05	0.00095	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	9.84e-05	0.000947	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	9.65e-05	0.000928	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	9.63e-05	0.000926	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	9.59e-05	0.000922	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	9.57e-05	0.000921	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	9.38e-05	0.000902	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	9.37e-05	0.000901	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ISYNA1—polycystic ovary syndrome	9.29e-05	0.000893	CbGpPWpGaD
Oxprenolol—CYP2D6—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	8.97e-05	0.000863	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—GHRL—polycystic ovary syndrome	8.88e-05	0.000854	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FLT4—polycystic ovary syndrome	8.78e-05	0.000844	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	8.74e-05	0.00084	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	8.71e-05	0.000838	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—GHRL—polycystic ovary syndrome	8.68e-05	0.000835	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FLT4—polycystic ovary syndrome	8.59e-05	0.000826	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—FSHR—polycystic ovary syndrome	8.55e-05	0.000822	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PDE3B—polycystic ovary syndrome	8.52e-05	0.000819	CbGpPWpGaD
Oxprenolol—Palpitations—Metformin—polycystic ovary syndrome	8.44e-05	0.0466	CcSEcCtD
Oxprenolol—ADRB1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	7.99e-05	0.000768	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—FSHR—polycystic ovary syndrome	7.93e-05	0.000763	CbGpPWpGaD
Oxprenolol—CYP2D6—Biological oxidations—CYP19A1—polycystic ovary syndrome	7.93e-05	0.000763	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—AKR1C2—polycystic ovary syndrome	7.9e-05	0.000759	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—TEAD2—polycystic ovary syndrome	7.9e-05	0.000759	CbGpPWpGaD
Oxprenolol—CYP2D6—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	7.82e-05	0.000752	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	7.82e-05	0.000752	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—FSHR—polycystic ovary syndrome	7.76e-05	0.000746	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	7.69e-05	0.00074	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NPB—polycystic ovary syndrome	7.67e-05	0.000738	CbGpPWpGaD
Oxprenolol—Thrombocytopenia—Metformin—polycystic ovary syndrome	7.63e-05	0.0422	CcSEcCtD
Oxprenolol—ADRB1—GPCR downstream signaling—LHB—polycystic ovary syndrome	7.6e-05	0.000731	CbGpPWpGaD
Oxprenolol—Hyperhidrosis—Metformin—polycystic ovary syndrome	7.54e-05	0.0416	CcSEcCtD
Oxprenolol—ADRB2—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	7.52e-05	0.000724	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NPB—polycystic ovary syndrome	7.5e-05	0.000722	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—LHB—polycystic ovary syndrome	7.43e-05	0.000715	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	7.43e-05	0.000714	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	7.35e-05	0.000707	CbGpPWpGaD
Oxprenolol—Hypotension—Metformin—polycystic ovary syndrome	7.29e-05	0.0402	CcSEcCtD
Oxprenolol—ADRB2—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	7.27e-05	0.000699	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	7.26e-05	0.000698	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—SCT—polycystic ovary syndrome	7.12e-05	0.000685	CbGpPWpGaD
Oxprenolol—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	7.1e-05	0.0392	CcSEcCtD
Oxprenolol—ADRB2—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	7.1e-05	0.000683	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	7.03e-05	0.000677	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	6.98e-05	0.000672	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—SCT—polycystic ovary syndrome	6.97e-05	0.00067	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	6.94e-05	0.000667	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—LHB—polycystic ovary syndrome	6.9e-05	0.000664	CbGpPWpGaD
Oxprenolol—Dyspepsia—Metformin—polycystic ovary syndrome	6.86e-05	0.0379	CcSEcCtD
Oxprenolol—ADRB2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	6.83e-05	0.000657	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—GNAS—polycystic ovary syndrome	6.81e-05	0.000655	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	6.79e-05	0.000653	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	6.79e-05	0.000653	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—LHB—polycystic ovary syndrome	6.75e-05	0.000649	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	6.75e-05	0.000649	CbGpPWpGaD
Oxprenolol—Fatigue—Metformin—polycystic ovary syndrome	6.72e-05	0.0371	CcSEcCtD
Oxprenolol—ADRB2—GPCR ligand binding—GNAS—polycystic ovary syndrome	6.67e-05	0.000641	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	6.65e-05	0.000639	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PNPLA2—polycystic ovary syndrome	6.62e-05	0.000636	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	6.6e-05	0.000635	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	6.54e-05	0.000629	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—SCT—polycystic ovary syndrome	6.47e-05	0.000622	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—LHCGR—polycystic ovary syndrome	6.4e-05	0.000616	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PTGER3—polycystic ovary syndrome	6.4e-05	0.000616	CbGpPWpGaD
Oxprenolol—CYP2D6—Biological oxidations—CYP1A1—polycystic ovary syndrome	6.39e-05	0.000615	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—SCT—polycystic ovary syndrome	6.33e-05	0.000608	CbGpPWpGaD
Oxprenolol—CYP2D6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	6.3e-05	0.000606	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—SRD5A1—polycystic ovary syndrome	6.27e-05	0.000603	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PTGER3—polycystic ovary syndrome	6.26e-05	0.000602	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—LHCGR—polycystic ovary syndrome	6.26e-05	0.000602	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	6.17e-05	0.000593	CbGpPWpGaD
Oxprenolol—Abdominal pain—Metformin—polycystic ovary syndrome	6.16e-05	0.034	CcSEcCtD
Oxprenolol—ADRB2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	6.03e-05	0.00058	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	6.03e-05	0.00058	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PTAFR—polycystic ovary syndrome	5.99e-05	0.000576	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—STAR—polycystic ovary syndrome	5.98e-05	0.000575	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	5.98e-05	0.000575	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	5.89e-05	0.000567	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PTAFR—polycystic ovary syndrome	5.86e-05	0.000563	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	5.81e-05	0.000559	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	5.69e-05	0.000547	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	5.66e-05	0.000544	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	5.62e-05	0.000541	CbGpPWpGaD
Oxprenolol—Asthenia—Metformin—polycystic ovary syndrome	5.59e-05	0.0309	CcSEcCtD
Oxprenolol—ADRB2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	5.53e-05	0.000532	CbGpPWpGaD
Oxprenolol—Pruritus—Metformin—polycystic ovary syndrome	5.52e-05	0.0305	CcSEcCtD
Oxprenolol—ADRB1—Signaling Pathways—INHBB—polycystic ovary syndrome	5.51e-05	0.00053	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—INHBB—polycystic ovary syndrome	5.39e-05	0.000519	CbGpPWpGaD
Oxprenolol—Diarrhoea—Metformin—polycystic ovary syndrome	5.33e-05	0.0295	CcSEcCtD
Oxprenolol—SLC22A2—Metabolism—HMMR—polycystic ovary syndrome	5.33e-05	0.000513	CbGpPWpGaD
Oxprenolol—Dizziness—Metformin—polycystic ovary syndrome	5.16e-05	0.0285	CcSEcCtD
Oxprenolol—ADRB1—Signaling Pathways—PDE3B—polycystic ovary syndrome	5.15e-05	0.000495	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	5.14e-05	0.000495	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	5.14e-05	0.000495	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—HSD3B1—polycystic ovary syndrome	5.09e-05	0.000489	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PDE3B—polycystic ovary syndrome	5.03e-05	0.000484	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	5.02e-05	0.000483	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	5.02e-05	0.000483	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	4.91e-05	0.000472	CbGpPWpGaD
Oxprenolol—Headache—Metformin—polycystic ovary syndrome	4.88e-05	0.027	CcSEcCtD
Oxprenolol—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	4.78e-05	0.00046	CbGpPWpGaD
Oxprenolol—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	4.77e-05	0.000458	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FSHR—polycystic ovary syndrome	4.69e-05	0.000451	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—LHB—polycystic ovary syndrome	4.64e-05	0.000446	CbGpPWpGaD
Oxprenolol—Nausea—Metformin—polycystic ovary syndrome	4.63e-05	0.0256	CcSEcCtD
Oxprenolol—ADRB1—GPCR ligand binding—POMC—polycystic ovary syndrome	4.59e-05	0.000441	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FSHR—polycystic ovary syndrome	4.58e-05	0.000441	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—GHRL—polycystic ovary syndrome	4.56e-05	0.000438	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—HSD3B2—polycystic ovary syndrome	4.53e-05	0.000436	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—POMC—polycystic ovary syndrome	4.49e-05	0.000432	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—GHRL—polycystic ovary syndrome	4.46e-05	0.000429	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	4.41e-05	0.000424	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—AKR1C1—polycystic ovary syndrome	4.39e-05	0.000422	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	4.31e-05	0.000415	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	4.29e-05	0.000412	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	4.19e-05	0.000403	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FST—polycystic ovary syndrome	4.18e-05	0.000402	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	4.15e-05	0.000399	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ADRB3—polycystic ovary syndrome	4.13e-05	0.000397	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FST—polycystic ovary syndrome	4.09e-05	0.000393	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—LHB—polycystic ovary syndrome	4.08e-05	0.000392	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	4.06e-05	0.000391	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	4.06e-05	0.000391	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—SULT2A1—polycystic ovary syndrome	4.04e-05	0.000389	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ADRB3—polycystic ovary syndrome	4.04e-05	0.000388	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—LHB—polycystic ovary syndrome	3.99e-05	0.000384	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GNRH1—polycystic ovary syndrome	3.98e-05	0.000383	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—RRM2—polycystic ovary syndrome	3.91e-05	0.000376	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GNRH1—polycystic ovary syndrome	3.9e-05	0.000375	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	3.86e-05	0.000371	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	3.85e-05	0.00037	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SCT—polycystic ovary syndrome	3.82e-05	0.000367	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	3.77e-05	0.000363	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—YAP1—polycystic ovary syndrome	3.77e-05	0.000363	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	3.77e-05	0.000363	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	3.77e-05	0.000362	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SCT—polycystic ovary syndrome	3.74e-05	0.000359	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	3.64e-05	0.000351	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—NAMPT—polycystic ovary syndrome	3.63e-05	0.000349	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FGF18—polycystic ovary syndrome	3.58e-05	0.000344	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CYP11A1—polycystic ovary syndrome	3.58e-05	0.000344	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	3.56e-05	0.000343	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—RBP4—polycystic ovary syndrome	3.55e-05	0.000342	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FGF18—polycystic ovary syndrome	3.5e-05	0.000337	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—GNAS—polycystic ovary syndrome	3.5e-05	0.000336	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—RBP4—polycystic ovary syndrome	3.47e-05	0.000334	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—GNAS—polycystic ovary syndrome	3.42e-05	0.000329	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	3.41e-05	0.000328	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—AKR1C3—polycystic ovary syndrome	3.38e-05	0.000325	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CYP17A1—polycystic ovary syndrome	3.33e-05	0.00032	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—YAP1—polycystic ovary syndrome	3.32e-05	0.000319	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GAB1—polycystic ovary syndrome	3.27e-05	0.000315	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—YAP1—polycystic ovary syndrome	3.24e-05	0.000312	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	3.23e-05	0.000311	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GAB1—polycystic ovary syndrome	3.2e-05	0.000308	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—INSR—polycystic ovary syndrome	3.13e-05	0.000301	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	3.08e-05	0.000296	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—INSR—polycystic ovary syndrome	3.06e-05	0.000294	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.97e-05	0.000286	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.92e-05	0.000281	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.91e-05	0.00028	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PGR—polycystic ovary syndrome	2.9e-05	0.000278	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—TH—polycystic ovary syndrome	2.88e-05	0.000277	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.86e-05	0.000275	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PGR—polycystic ovary syndrome	2.83e-05	0.000272	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—SLC2A4—polycystic ovary syndrome	2.8e-05	0.000269	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	2.75e-05	0.000264	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GHRL—polycystic ovary syndrome	2.69e-05	0.000259	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PLAT—polycystic ovary syndrome	2.69e-05	0.000259	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CYP19A1—polycystic ovary syndrome	2.63e-05	0.000253	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PLAT—polycystic ovary syndrome	2.63e-05	0.000253	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GHRL—polycystic ovary syndrome	2.63e-05	0.000253	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	2.62e-05	0.000252	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.59e-05	0.000249	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ATF1—polycystic ovary syndrome	2.57e-05	0.000247	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.54e-05	0.000244	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ATF1—polycystic ovary syndrome	2.51e-05	0.000242	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.5e-05	0.000241	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.49e-05	0.00024	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.45e-05	0.000236	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.44e-05	0.000234	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	2.39e-05	0.00023	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NGFR—polycystic ovary syndrome	2.37e-05	0.000228	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—POMC—polycystic ovary syndrome	2.35e-05	0.000226	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GNAS—polycystic ovary syndrome	2.35e-05	0.000226	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PRL—polycystic ovary syndrome	2.35e-05	0.000226	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	2.33e-05	0.000225	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NGFR—polycystic ovary syndrome	2.32e-05	0.000223	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—POMC—polycystic ovary syndrome	2.3e-05	0.000222	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PRL—polycystic ovary syndrome	2.3e-05	0.000221	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.26e-05	0.000218	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	2.26e-05	0.000217	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—NCOR1—polycystic ovary syndrome	2.24e-05	0.000215	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.23e-05	0.000214	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.21e-05	0.000213	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CYP1A1—polycystic ovary syndrome	2.12e-05	0.000204	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	2.08e-05	0.0002	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GNAS—polycystic ovary syndrome	2.07e-05	0.000199	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GNAS—polycystic ovary syndrome	2.02e-05	0.000194	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	2.02e-05	0.000194	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—MTHFR—polycystic ovary syndrome	1.98e-05	0.00019	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.97e-05	0.000189	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	1.94e-05	0.000187	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NRG1—polycystic ovary syndrome	1.93e-05	0.000186	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.93e-05	0.000185	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NRG1—polycystic ovary syndrome	1.89e-05	0.000182	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	1.87e-05	0.000179	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	1.84e-05	0.000177	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	1.74e-05	0.000167	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	1.71e-05	0.000165	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IRS2—polycystic ovary syndrome	1.65e-05	0.000159	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—LEP—polycystic ovary syndrome	1.62e-05	0.000156	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IRS2—polycystic ovary syndrome	1.62e-05	0.000156	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PPARG—polycystic ovary syndrome	1.61e-05	0.000154	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—LEP—polycystic ovary syndrome	1.58e-05	0.000152	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—POMC—polycystic ovary syndrome	1.58e-05	0.000152	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—INS—polycystic ovary syndrome	1.57e-05	0.000151	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—TH—polycystic ovary syndrome	1.48e-05	0.000143	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IRS1—polycystic ovary syndrome	1.44e-05	0.000139	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	1.44e-05	0.000139	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IRS1—polycystic ovary syndrome	1.41e-05	0.000136	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—POMC—polycystic ovary syndrome	1.39e-05	0.000134	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—INS—polycystic ovary syndrome	1.38e-05	0.000133	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—POMC—polycystic ovary syndrome	1.36e-05	0.000131	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	1.36e-05	0.00013	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—INS—polycystic ovary syndrome	1.35e-05	0.00013	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IGF1—polycystic ovary syndrome	1.34e-05	0.000129	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AKT2—polycystic ovary syndrome	1.34e-05	0.000129	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IGF1—polycystic ovary syndrome	1.31e-05	0.000126	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AKT2—polycystic ovary syndrome	1.31e-05	0.000126	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.27e-05	0.000122	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.24e-05	0.00012	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	1.21e-05	0.000116	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	1.15e-05	0.000111	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	1.09e-05	0.000105	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—IL6—polycystic ovary syndrome	1.02e-05	9.84e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	1.02e-05	9.8e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—IL6—polycystic ovary syndrome	1e-05	9.63e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.74e-06	8.41e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.55e-06	8.22e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	8.26e-06	7.95e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	8.15e-06	7.84e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—INS—polycystic ovary syndrome	8.1e-06	7.79e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IL6—polycystic ovary syndrome	6.04e-06	5.81e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IL6—polycystic ovary syndrome	5.91e-06	5.69e-05	CbGpPWpGaD
